The mechanisms involved in transition through the Cl phase of the cell cycle are quite different for the two types of liver regeneration.
However, once the hepatocyte is committed to replication, progression through the cell cycle appears to be the same for both types of growth. The characteristics of mitogen-induced direct hyperplasia also appear to depend on the type of mitogen involved. For example, the pattern of ploidy, the perturbation in cytokinesis, and the incidence of multinucleate cells are very different in direct hyperplasia induced by lead nitrate vs. that induced by the peroxisome proliferator nafenopin.
However, one common characteristic remains intact:
as soon as the mitogenic stimulus is withdrawn, liver mass and DNA content return to their original values, regressing through what appears to be the well-controlled process of apoptosis.
In liver regeneration by direct hyperplasia, we become aware of a host of new players, including nuclear receptors for peroxisome proliferators such as clofibrate and the retinoid X receptor for 9-cis retinoic acid. We are also reintroduced to a set of old players including nonparenchymal cells and TNF-a.
If it begins to seem logical, try to explain why direct hyperplasia is far less effective in initiation of chemical hepatocarcinogenesis than compensatory regeneration. Thus, the models of direct liver hyperplasia may serve as an additional tool to gain clearer insights into molecular mechanisms of liver cell proliferation.
In this paper, we will review the current state of knowledge on primary liver mitogens and highlight differences between the two types of cell proliferation.
DEFINITION

AND TYPES
OF DIRECT MITOGENS
As already indicated, liver cell growth can be induced by two distinct patterns: compensatory regeneration and direct hyperplasia.
The differences in these two conditions are depicted in Fig. 1 . In compensatory regeneration, initiation of hepatocyte DNA synthesis is preceded by a loss of liver cells, such as seen after PH or liver necrosis, whereas in direct hyperplasia, hepatocyte DNA synthesis is directly stimulated without cell loss. Table  1 lists diverse agents that have been characterized as direct mitogens. and the list will increase as more agents are tested. Although most of these agents are well-defined chetnicals, peroxisome proliferators (PPs) include a broad spectrum of chemicals with little structural similarity but
Iossess some common properties such as lowering of serum lipids, eliciting proliferation of peroxisomes, and inducing hepatocyte proliferation (5) . After a single dose of the agents listed, the initial event is an enhanced proliferation of liver cells that can result in a doubling of hepatic DNA within 2-3 days. The potency of the mitogenic stimulus and the peaks of the S phase vary according to the nature of agents.
After mitogen withdrawal, rapid elimination of the induced cell excess occurs, probably via apoptosis (6) . Several other chemicals, not listed in Table 1, can be considered as primary mitogens, such as phenobarbital and estrogen. We did not include these In the former type, cell loss, due either to surgical removal or necrosis induced by hepatoxicants, is the initial event and liver cell proliferation is triggered to compensate cellular loss; proliferation stops once the liver has regained its original mass. In the latter type (direct hyperplasia), liver cell proliferation, which is now the initial event, generates an excess of cells. After mitogen withdrawal, regression of the initial hyperplasia occurs, probably via apoptosis.
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INVOLVEMENT
OF GROWTH FACTORS
As reviewed elsewhere, extensive studies using isolated hepatocytes in primary culture have identified growth stimulatoty factors such as hormones, nutrients, peptide growth factors, and cytokines (7) (8) (9) . Among them, hepatocyte growth factor (HGF) and transforming growth factor alpha (TGF-a) are two of the most powerful stimulators of hepatocyte DNA synthesis in vitro. Possible involvement of these growth factors in in vivo liver regeneration came from the observation that the appearance of HGF in serum and the expression of HGF and TGF-a in the liver precede hepatocyte proliferation after PH (8, 10) . However, unequivocal evidence that they act as regulators of liver growth in vivo is lacking. In fact, several reports indicate that administration of HGF or TGF-a to intact animals is ineffective in eliciting hepatocyte DNA synthesis. It is currently believed that some preparatory changes (priming) must occur in the liver in order for growth factors to trigger hepatocyte DNA synthesis (11) . The results obtained so far cast doubt on the involvement of HGF and TGF-a in direct mitogen-induced hepatocyte proliferation. Indeed, there were no significant changes in the levels of liver HGF or TGF-a mRNA after a single dose of the metal salt lead nitrate (LN) or BR931, a PP (12, 13) . Even a slight decrease in the levels of HGF mRNA was noted after BR931 treatment.
Furthermore, it was shown that whereas liver cell proliferation consequent to chronic cell death induced by a choline-deficient diet is associated with increased levels of both HGF and TGF-a mRNA, a decrease in HGF mRNA was found during liver cell proliferation induced by feeding a diet containing BR931 (14). Similarly, cyclosporine, which stimulates liver cell proliferation, also showed no significant changes in liver HGF mRNA (15).
In these studies, no enhanced levels of HGF mRNA in the lung or the kidney were observed in rats fed BR931 or cyclosporine, thus making the possibility of an increase in circulating HGF due to its production by distant organs very unlikely.
It Moreover, no changes in the hepatic levels of c-jun and c-myc mRNA were detected in liver cell proliferation induced by CPA and nafenopin (19, 20) . Note that in all these experiments, Northern blot analysis of liver of rats subjected to PH or carbon tetrachloride (CCI4) as a positive control showed induction of c-fos, c-jun. and c-myc expression shortly after treatment. These results thus show that c-fos is not required for liver cell proliferation induced in the rat liver by primary mitogens, and suggest that, depending on the nature of the mitogen used, c-jun and c-myc may also be irrelevant for this model of liver growth. This conclusion is further supported by our recent findings that BR931, a powerful mitogenic agent of the class of PPs, induces a rapid onset of DNA synthesis in the absence of any detectable increase in hepatic mRNA levels of immediate 
early genes such as egr-l, LRF-1, and c-myc (13) . It is possible that activation of this set of genes reflects an "alert" pathway triggered when liver cells are exposed to a potentially dangerous damage rather than a "mitogenic" program.
Indeed, after injury with CC14, an increased transcription of c-fos, c-jun, and c-myc was observed in virtually all hepatocytes of zone III (more damaged cells), but not in zone I (where regeneration starts) (22). Moreover, liver cell death rapidly occurring after PH in rats fed a vitamin A-deficient diet was associated with an increase in the expression of c-jun and c-fos much higher than that seen in PH animals fed a basal diet (23).
Activation of the transcription factor NF-KB observed 30 mm after PH has been suggested to play a role in making hepatocytes competent to proliferate (24, 25). However, even though our studies and studies by others confirmed a rapid transient activation of NF-KB shortly after PH, activation of this transcriptional factor was not observed during hyperplasia induced by BR931 (13) . Similarly, whereas liver regeneration after CC14 is accompanied by an increased activation of both NF-KB and AP-1, no such increase was found in nafenopin-induced liver cell proliferation (unpublished results). These observations suggest that different signal transduction pathways may be involved in triggering hepatocyte proliferation depending on 1) the nature of the proliferative stimulus (compensatory vs. direct hyperplasia) and 2) the type of the primary mitogen. Patterns of NF-KB activation, immediate early gene, atid growth factor gene expression after compensatory and direct hyperplasia are summarized in Table 2 .
TUMOR NECROSIS FACTOR-a (TNF-a) IN DIRECT HYPERPLASIA
An obvious question can be raised: What factors are involved in mitogen-induced direct hyperplasia? A possible role for TNF-a on LN-induced liver cell proliferation was considered, based on the old observation that lead sensitized animals to the lethal effect of bacterial lipopolysaccharide (26), the effects probably being mediated by TNF-a. A single dose of LN, which is nonnecrogenic but mitogenic to the liver, induced a rapid increase in TNF-a mRNA in the liver at times that precede DNA synthesis (12) . EDB, another direct mitogen, also induced similar effects (27 TNF-a production after PH could be demonstrated (38), necrotic foci were observed, which suggests that the increased TNF'-a production could be triggered as part of the inflammatory reaction associated with tiecrosis.
Based on these observations, one may be tempted to speculate that TNF-a might be the critical "growth factor" not only for direct hyperplasia, but also for liver regeneration.
However, there is no evidence of involvement of this cytokine when liver hyperplasia was induced by PP such as BR931 and nafenopin (13) . Furthermore, these hypolipidemic agents did not stimulate proliferation of nonparenchymal cells before the onset of hepatocyte DNA synthesis. stimuli, it appears that a reduction in binucleation of hepatocytes, such as that seen after PH, is not necessarily associated with liver cell proliferation induced by acute treatment with some direct mitogens (Table 3) . More detailed studies of the ploidy state of the liver during direct hyperplasia are also needed in order to establish with accuracy whether and how the increase in DNA content induced by primary mitogens correlates with increase in cell number. Hyperplasia induced by LN, for example, results in a doubling of DNA content; however, because of the increase in ploidy due to induction of binucleate hepatocytes, the increase in cell number seems to be limited to only about 25% (55). On the other hand, the finding that other mitogens do not seem to increase the ploidy state of hepatocytes (60, 61) suggests that the increase in DNA content observed in the liver of rats treated with these mitogens reflects an increase in cell number. No increase in the serum levels of enzymes commonly released during necrosis or inflammation can be observed under these conditions.
NUCLEAR HORMONE RECEPTORS
The fact that apoptosis occurs only when DNA content has reached its maximutn and stops once the DNA content has regained its original value suggests that the process represents a homeostatic adjustment (i.e., removal of excess cells generated by the mitogenic event) and does not appear to be the consequence of the toxicity of the chemical.
As 
CELL PROLIFERATION AND HEPATOCARCINOGENESIS
Hepatic cell proliferation is considered to play an important role in the several steps of the carcinogenic process: initiation, promotion, and progression (76) . Although the exact mechanism whereby cell proliferation plays a role in initiation is not known, its itivolvement in events such as fixation of a miscoding lesion in the newly made DNA has been entertained (77) . In most studies aimed to determine the role of cell proliferation in the initiation step of chemical hepatocarcinogetiesis, the proliferative stimulus has been achieved by compensatory regeneration. Untier these conditions, liver regeneration is indeed a necessaty event for initiation by chemicals. But it is also evident that doses of carcinogen that induced an initiation event when coupled with liver regeneration failed to initiate liver cells when coupled with proliferation induced by direct mnitogens (78) . Failure of direct hyperplasia to support initiation by chemical carcinogens was observed despite the presence of DNA damage. Whether the inability is due to the lack of some molecular event required for initiation or whether initiated cells are formed, but are preferentially eliminated by apoptosis during the successive regression of the initial hyperplasia, is still unclear. It has been suggested that deletion of numerous carcinogeti-altered cells occurs "spontaneously" shortly after initiation (79) . A second site at which cell proliferation exerts a critical effect is the promotion of carcinogen-initiated cells. Iticreased incidence of preneoplastic lesions and tumors has been observed when carcinogen treatment was followed by compensatory regeneration induced by repeated PH or multiple treatment with necrogenic agents (80-82). On the other hand, the effect of direct mitogens on the growth of carcitiogen-induced preneoplastic hepatocyte is far less clear, due in part to the complete carcinogenic action of PP, the prototype of direct mitogens (83). However, some studies suggest that PPs have the capacity to induce the disappearance of 'y-glutamyltranspeptidase (GGT) -positive preneoplastic lesions induced by genotoxic compounds (84, 85). For some time this effect was attributed to the inhibitory effect of these mitogens on the marker enzyme used to identify preneoplastic lesion, and not to a real growth inhibitory effect. However, recently Chen et al. (86) have shown that the PP cyprofibrate reduced from 40% to less than 5% the labeling index of preneoplastic nodules generated by the Salt-Farber pro-
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For direct mitogens other than PP, repeated treatment with CPA promoted the growth of diethylnitrosamine (DENA) -induced GGT positive foci, and this enhancing effect was considered to be the result of mitogenic activity of CPA (87). However, the recent demonstration of the genotoxic activity of CPA (88) raises the possibility that the effect observed on progression of preneoplastic lesion may be the consequence of the several episodes of DNA damage induced by CPA. On the other hand, no promoting effect on the growth of DENA-induced GGT-positive foci was observed after repeated treatment with mitogens such as LN or EDB (82) despite a very high extent of cell proliferation, raising the possibility that either putative preneoplastic cells do not respond to the proliferative stimulus elicited by these mitogens or they may respond as efficiently as normal hepatocytes, but die via apoptosis occurring during the regression of the initial hyperplasia. Inasmuch as direct hyperplasia induced by acute treatment with primary mitogens, unlike compensatory regeneration, has no significant effects on either initiation or promotion of carcinogenesis (72) , efforts must be made to reevaluate roles of enhanced cell proliferation on genesis of cancer. It would be particularly important to determine whether cell proliferation induced by physiological agents such as T3 and 9-cis retinoic acid has any role in modifying carcinogenic processes.
CONCLUSIONS: FROM P (PROMETHEUS) TO PP (PEROXISOME PROLIFERATORS)
Liver regeneration has been for many years the only model used to study the biological and molecular mechanisms controlling liver cell growth. This is not surprising, because ever since the time of ancient Greece, liver regeneration was the only in vivo model Prometheus had provided (PP had not yet come to life). However, unlike the ancient Greeks, we know now that liver cell proliferation can also be induced by many chemicals, termed direct mitogens.
Although liver regeneration still offers an attractive model for studying regulatory mechanisms that control liver growth, the models of direct hyperplasia provide additional means to define how liver cell growth is controlled in the body, as the mitogens act on the liver without serious damage.
At least two plausible mechanisms of actions of direct mitogens have been postulated: 
